Phase II trial of gemcitabine, carboplatin, and bevacizumab (Bev) in patients (pts) with advanced/metastatic urothelial carcinoma (UC).

被引：1
|
作者：
Balar, A. V.
Milowsky, M. I.
Apolo, A. B.
Ostrovnaya, I.
Iasonos, A.
Trout, A.
Regazzi, A. M.
Garcia-Grossman, I. R.
Gallagher, D. J.
Bajorin, D. F.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] NCI, Med Oncol Branch, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.4566
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4566
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM)
    Holmsten, Karin
    Jensen, Niels Viggo
    Mouritsen, Lene Sonne
    Jonsson, Erika
    Mellnert, Camilla
    Agerbaek, Mads
    Nilsson, Cecilia
    Moe, Mette
    Carus, Andreas
    Ofverholm, Elisabeth
    Lahdenpera, Outi
    Brandberg, Yvonne
    Johansson, Hemming
    Hellstrom, Mats
    von der Maase, Hans
    Pappot, Helle
    Ullen, Anders
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 127 : 173 - 182
  • [32] A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
    Xu, Nong
    Zhang, Xiao Chen
    Xiong, Jian Ping
    Fang, Wei Jia
    Yu, Lan Fang
    Qian, Jiong
    Zhang, Ling
    [J]. BMC CANCER, 2007, 7 (1)
  • [33] A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma
    Fuchs, CS
    Clark, JW
    Ryan, DP
    Kulke, MH
    Kim, H
    Earle, CC
    Vincitore, M
    Mayer, RJ
    Stuart, KE
    [J]. CANCER, 2002, 94 (12) : 3186 - 3191
  • [34] A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
    Nong Xu
    Xiao Chen Zhang
    Jian Ping Xiong
    Wei Jia Fang
    Lan Fang Yu
    Jiong Qian
    Ling Zhang
    [J]. BMC Cancer, 7
  • [35] A phase II trial of paclitaxel, carboplatin, and bevacizumab in advanced and recurrent endometrial carcinoma (EMCA)
    Simpkins, Fiona
    Drake, Richard
    Escobar, Pedro F.
    Nutter, Benjamin
    Rasool, Nabila
    Rose, Peter G.
    [J]. GYNECOLOGIC ONCOLOGY, 2015, 136 (02) : 240 - 245
  • [36] Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer
    Carles, J.
    Esteban, E.
    Climent, M.
    Font, A.
    Gonzalez-Larriba, J. L.
    Berrocal, A.
    Garcia-Ribas, I.
    Marfa, X.
    Fabregat, X.
    Albanell, J.
    Bellmunt, J.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (08) : 1359 - 1362
  • [37] Gemcitabine and oxaliplatin combination:: A multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer
    Carles, Joan
    Esteban, E.
    Climent, M.
    Font, A.
    Gonzalez-Larriba, J. L.
    Berrocal, A.
    Fabregat, X.
    Albanell, J.
    Bellmunt, J.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 151 - 152
  • [38] A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma
    Gitlitz, BJ
    Baker, C
    Chapman, Y
    Allen, HJ
    Bosserman, LD
    Patel, R
    Sanchez, JD
    Shapiro, RM
    Figlin, RA
    [J]. CANCER, 2003, 98 (09) : 1863 - 1869
  • [39] Erdafitinib in high-risk patients (pts) with advanced urothelial carcinoma (UC).
    Park, Se Hoon
    Loriot, Yohann
    Zhong, Bob
    Hussain, Syed A.
    Mahadevia, Parthiv Jasvant
    De Porre, Peter
    Siefker-Radtke, Arlene O.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma - A phase II trial using a triplet combination
    Leong, SS
    Wee, J
    Tay, MH
    Toh, CK
    Tan, SB
    Thng, CH
    Foo, KF
    Lim, WT
    Tan, T
    Tan, EH
    [J]. CANCER, 2005, 103 (03) : 569 - 575
12345